SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-23-000931
Filing Date
2023-09-14
Accepted
2023-09-14 21:17:56
Documents
1
Period of Report
2023-08-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11716
  Complete submission text file 0000947871-23-000931.txt   13047
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Bonita David P (Reporting) CIK: 0001572451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40287 | Film No.: 231256460

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)